SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-055157
Filing Date
2005-11-14
Accepted
2005-11-14 10:38:13
Documents
4
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-18201_110q.htm 10-Q 667920
2 302 CERTIFICATION a05-18201_1ex31d1.htm EX-31.1 10393
3 302 CERTIFICATION a05-18201_1ex31d2.htm EX-31.2 10411
4 906 CERTIFICATION a05-18201_1ex32.htm EX-32 7043
  Complete submission text file 0001104659-05-055157.txt   697252
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 051197679
SIC: 2834 Pharmaceutical Preparations